Target intelligence / Profile preview

Plasmodium species asexual blood stage

Molecular classification
Other (eukaryotic unicellular parasite life stage; not a single molecule, but a developmental phase consisting of various targets including enzymes, transporters, and organelles)
01

Overview

The Plasmodium species asexual blood stage encompasses the period when malaria parasites actively invade and multiply within human erythrocytes (red blood cells). After being released from the liver as merozoites, Plasmodium invades red blood cells and undergoes repeated cycles of growth and division (schizogony), leading to exponential increases in parasite numbers. This stage is responsible for most clinical symptoms of malaria, as parasites digest host hemoglobin, causing anemia and releasing metabolic waste that triggers fever and inflammation. Key cellular processes include hemoglobin ingestion, glycolytic ATP production, heme detoxification into hemozoin, and immune evasion. Asexual blood stages are the main target for most antimalarial drugs, and their effective clearance is essential to treat malaria and prevent morbidity and mortality.

Other names
Plasmodium asexual blood stagePlasmodium intraerythrocytic (red blood cell) stagePlasmodium erythrocytic stagePlasmodium trophozoite/schizont stage
02

Mechanism of action

Inhibition of hemoglobin digestion; Disruption of heme detoxification; Inhibition of DNA/RNA synthesis and replication; Inhibition of mitochondrial electron transport chain; Inhibition of folate pathway enzymes; Disruption of membrane processes

03

Biological functions

Cell proliferation (schizogony: repeated asexual replication)Erythrocyte invasion and parasitismHemoglobin digestionATP synthesis via glycolysisHeme detoxification (formation of hemozoin)Other (metabolic remodeling, immune evasion)
04

Disease associations

Infection (malaria)
05

Safety considerations

Drug resistance developmentPotential toxicity of antimalarial drugs (neurotoxicity, cardiotoxicity, hemolysis)Host immune response and hemolytic anemiaDifficulties in targeting only parasite without affecting host cells
06

Interacting drugs

Chloroquine

9 more in the full profile.

07

Biomarkers

Parasitemia level (number of asexual parasites per microliter)Malaria rapid diagnostic test antigens (e.g., HRP2, LDH)Blood smear microscopy (visualization of rings, trophozoites, schizonts)Lactate levels (associated with high parasite burden/severe disease)

Beyond the preview

Go deeper on Plasmodium species asexual blood stage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium species asexual blood stage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call